BIOMERICA INC Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
BIOMERICA INC (BMRA) reported Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $0.71 per share for the 12-month period ending 2019-05-31, per its 10-K filed 2020-08-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2020-08-31
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2018-08-31 was $0.83.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2016-11-30 was $0.43.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2016-08-31 was $1.52.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2019 was $0.71, a 0.00% change from fiscal 2018.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2018 was $0.71, a 65.12% increase from fiscal 2017.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2017 was $0.43, a 13.16% increase from fiscal 2016.
- BIOMERICA INC share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2016 was $0.38, a 0.00% change from fiscal 2015.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 9 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 12 month |
|---|---|---|---|---|
| 2019-05-31 | $0.71 10-K · filed 2020-08-31 | |||
| 2019-02-28 | $0.71 10-Q · filed 2019-04-15 | |||
| 2018-11-30 | $0.71 10-Q · filed 2019-01-14 | |||
| 2018-08-31 | $0.83 10-Q · filed 2018-10-15 | |||
| 2018-05-31 | $0.71 10-K · filed 2018-08-29 | |||
| 2018-02-28 | $0.71 10-Q · filed 2018-04-16 | |||
| 2017-11-30 | $0.71 10-Q · filed 2018-01-17 | |||
| 2017-05-31 | $0.43 10-K · filed 2018-08-29 | |||
| 2017-02-28 | $0.43 10-Q · filed 2017-04-14 | |||
| 2016-11-30 | $0.43 10-Q · filed 2017-01-17 | |||
| 2016-08-31 | $1.52 10-Q · filed 2016-10-17 | |||
| 2016-05-31 | $0.38 10-K · filed 2017-08-29 | |||
| 2015-05-31 | $0.38 10-K · filed 2016-08-29 | |||
| 2014-05-31 | $0.38 10-K · filed 2015-08-31 | |||
| 2013-05-31 | $0.30 10-K · filed 2013-08-29 | |||
| 2012-05-31 | $0.38 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |